Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment.
D000535:Aluminum / Q000009:adverse effects* / Q000032:analysis; D001927:Brain Diseases / Q000139:chemically induced / Q000188:drug therapy*; D003676:Deferoxamine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D006435:Renal Dialysis / Q000009:adverse effects*; D014881:Water Supply / Q000032:analysis
D000535:Aluminum; D003676:Deferoxamine